4DMedical is trading at A$3.80, down 6.86% from the prior close of A$4.08; no specific company announcement or catalyst explaining the October 14 decline was identified.

  • Supplied market context reports declines in major U.S. indices amid hotter-than-forecast inflation and higher-rate concerns.
  • Broader risk-off sentiment may have contributed, but it is not a confirmed direct cause of 4DMedical’s move.